What Medixine does

Medixine Ltd. is a Finnish health technology company founded in 2000 by physician Tapio Jokinen and headquartered in Espoo, Finland, with a stated team of approximately 25 experts. The company built and commercialised Medixine Suite, an all-in-one cloud-based telehealth platform for remote patient monitoring, digital health questionnaires, automated triage and screening, video consultations, and secure messaging, configurable via Open APIs and integrable with more than 20 Bluetooth-connected medical devices from manufacturers including Garmin, Nonin, Omron, Beurer, A&D, ForaCare, Vitalograph, and others. Medixine Suite is certified as a CE Mark Class IIa medical device under EU MDR 2017/745 and the company operates under EN ISO 13485:2016, positioning the platform for regulated European tenders and clinical deployments.

The business sells primarily through enterprise SaaS subscriptions on annual contracts to hospitals, hospital districts, NHS trusts, and home-care providers, with quote-based pricing rather than published tiers. Beyond direct sales, Medixine licenses and white-labels the platform to channel and OEM partners, including CGI, EVRY, Kauko/Codeground, Techtools (Brazil), Movsa (Spain), Howz (UK), IEM GmbH (Germany), Linde/Lincare (U.S.), Tunstall Healthcare (global), and Nonin Medical (U.S.), with named end customers including NHS Surrey and Borders Partnership, Pirkanmaa Hospital District, Hospital General Universitario de Valencia, Nestlé Health Science, Roche, Novartis, and UCB. The stated patient population base is 2.5 million across at least 8 countries (Finland, Sweden, Norway, Denmark, Spain, Portugal, the UK, and the U.S., plus reach into Germany and Brazil).

The company was bootstrapped via consulting and pilots for its first 15 years before launching the Suite platform in 2015, and has since raised approximately €7.9 million in funding, primarily through Springvest-organised rounds in 2021 (€2.9M) and 2022 (€5M). Earlier investors include Finnish Innovation Fund Sitra and Vendep Capital. CEO Lasse Rousi, appointed in 2019 from CGI, has led the internationalisation phase, with the most recent strategic emphases being the U.S. market (Lincare deployment, Nonin Health platform, U.S. advisory additions in 2025) and the OEM-led global rollout with Tunstall Healthcare starting in 2026.

Name

Medixine

Legal name

Medixine Ltd.

Website

https://medixine.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Medixine is a Finnish health technology company that develops Medixine Suite, an all-in-one CE-marked Class IIa telehealth platform for remote patient monitoring, triage, video consultations and secure messaging, sold to hospitals, NHS trusts, home-care providers and OEM partners across Europe, the UK, and the U.S.

Ownership category

akta.pro rank

Product category

Telehealth Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

• Remote patient monitoring
• Telehealth platform
• Medical device software
• Connected care solutions
• Chronic disease monitoring

Headquarters

HQ city

Espoo

HQ country

Finland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

1. Software Platform/SaaS Subscription: Medixine Suite is sold as a software platform to healthcare providers, hospitals, and healthcare organizations. The platform is offered as a cloud-based SaaS solution with configurable modules. Revenue is generated through licensing the platform to customers across multiple countries. The company also offers white labeling and embedding options for partners.
2. Platform Licensing to Partners/OEMs: Medixine licenses its platform technology to partners including IEM GmbH (Germany), Howz (UK), Techtools (Brazil), and others who embed or white label the technology for their own customers. This generates licensing revenue streams.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

Medixine Suite is a cloud-based all-in-one telehealth platform for remote patient monitoring, communication, and collaboration. The platform integrates with Bluetooth-connected medical measurement devices (blood pressure monitors, pulse oximeters, glucose meters, scales, wearables) to collect patient health data in real time. It supports remote patient monitoring, video consultations, secure messaging, health questionnaires, and triage/screening, and is certified as a CE Mark Class IIa medical device under EU MDR 2017/745.

Product overview

Medixine offers Medixine Suite, a modular all-in-one telehealth platform for virtual care and remote patient monitoring. The platform consists of a core software solution plus integrated modules including Remote Patient Monitoring (for vital sign tracking with Bluetooth-connected devices), Forms and Questionnaires (for health screening and data collection), Triage & Screening (for automated patient prioritization), Video Consultations, Secure Messages, and Secure Chat. Medixine Suite is a CE Mark certified Class IIa medical device under MDR, deployed across 8 countries covering 2.5 million patients. The platform integrates with various medical devices (A&D, Nonin, Omron, Beurer, Garmin, Vitalograph, and others) for continuous health data collection.

Differentiator

Problem solved

Functional benefit

Brands

• Medixine Suite: All-in-one remote care platform integrating remote patient monitoring, video consultations, secure messaging, health questionnaires, and automated screening.

Products and services

• Medixine Suite All-in-one cloud-based telehealth platform for communication, monitoring, and collaboration between healthcare professionals and patients. Enables remote patient monitoring, automated screening, video consultations, secure messaging, and health questionnaires for any illness or condition. Certified as a CE Mark Class IIa medical device under EU MDR and ISO 13485:2016.

Quantifiable outcome

• 40% reduction in manual triage work
• +3 more outcomes

Named customers12 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration12 records

Feature8 records

Partnerships

17 partnerships are on record, tiered core and minor.

• Tunstall HealthcarecoreStrategic or Co-development Partner · 21 January 2026Tunstall Healthcare, a global leader in connected care and health monitoring, selected Medixine Suite to serve as the foundation for its next-generation remote care services. The new Tunstall solution went live in summer 2025 and is now expanding to all Tunstall countries. The collaboration brings together Tunstall's long-standing expertise in telecare and digital health with Medixine's proven cloud-based technology platform, providing a flexible, scalable, and secure framework for continuous digital care across multiple regions.
• Nonin MedicalcoreStrategic or Co-development Partner · 18 February 2024Medixine and Nonin Medical partnered to co-develop remote digital monitoring services for more patient-centric diagnosis of chronic conditions. The result is the Nonin Health platform built on Medixine's technology, making Nonin pulse oximetry data available wherever care happens. The platform enables real-time pulse oximetry data for clinicians, streamlining workflows. Now live with selected providers in the United States with broader rollout planned.
• Movsa (Spain)coreChannel Partner/ Reseller/ Distributor · 1 March 2023Movsa is Medixine's local partner in Spain for the Valencia chronic heart disease monitoring program. The partnership combined Medixine's technology platform with Movsa's deep local market knowledge to quickly enter the Spanish market. Medixine Suite is used in a clinical trial with Hospital General Universitario de Valencia and Novartis for chronic heart disease patients.
• NovartiscoreStrategic or Co-development Partner · 1 January 2023Novartis partnered with Medixine and Movsa for a clinical trial in Valencia, Spain, using Medixine Suite to monitor patients with chronic heart disease. The trial is conducted in cooperation with the Valencian Community and Hospital General Universitario de Valencia.
• RochecoreStrategic or Co-development Partner · 5 October 2022Roche and Medixine announced cooperation for more effective treatment and savings in healthcare through remote monitoring of heart diseases. The partnership aims to improve chronic heart disease management and reduce healthcare costs through integrated digital health solutions.
• Howz (Intelesant Ltd)coreStrategic or Co-development Partner · 1 January 2021Howz, a UK smart home monitoring provider, partnered with Medixine for the TIHM Monitoring Service supporting NHS Covid response in Surrey. The combination of Howz Smart Home Kit and Medixine Suite monitors dementia patients and their carers. The service is provided by Surrey and Borders Partnership NHS Foundation Trust, Howz, and Surrey County Council. This was the first service launched following the successful NHS TestBed with over 400 people receiving the service.
• City of EspoominorStrategic or Co-development Partner · 1 January 2021The City of Espoo piloted a digital well-being assessment tool built using Medixine Suite's advanced questionnaires. The tool is used for adult population self-assessment in social work, developed in cooperation with Socca, the Centre of Excellence on Social Welfare in the Helsinki Metropolitan Area.
• Techtools (Brazil)coreChannel Partner/ Reseller/ Distributor · 20 October 2020Techtools, a Brazilian group of companies dedicated to healthcare quality and efficiency serving 2000+ hospitals, signed a cooperation agreement with Medixine for the Brazilian market. COVID-19 accelerated telemedicine adoption in Brazil and Techtools selected Medixine to provide comprehensive remote care solutions with robust clinical protocols.
• UCBminorStrategic or Co-development Partner · 1 January 2020UCB, a global biopharma company, started a project to develop and pilot disease-specific connected care solutions using Medixine Suite. UCB chose Medixine based on its flexible and easily configurable platform, rich framework for connected devices, and proven large-scale international deployments.
• Finnish Institute of Molecular Medicine (FIMM) and University of HelsinkiminorStrategic or Co-development Partner · 1 January 2020FIMM and University of Helsinki used Medixine Suite in the GeneRisk research project studying COVID-19 morbidity and genetic/health information effects. The comprehensive data collection tools enabled fast and high-quality COVID-19 research data collection.
• Linde Healthcare / LincarecoreStrategic or Co-development Partner · 1 January 2019Long-standing collaboration between Medixine and Linde Healthcare since 2019 for providing remote patient monitoring services. Lincare (US subsidiary of Linde) uses Medixine platform for a new remote monitoring program for COPD patients. Service initially rolled out in Florida with plans to expand across the US. Lincare covers approximately two million patients in 48 states.
• IEM GmbH (Germany)coreOEM/ Whitelabel/ Licensing Partner · 1 January 2019IEM GmbH, a pioneer in telehealth devices (blood pressure meters, scales) based in Stolberg, Germany, selected Medixine Suite as their cloud platform internationally. Healthcare customers from GPs to high-end hospitals can now use Medixine Suite-based cloud service with IEM connected devices. First production sites expected during the year of selection.
• Kauko (Germany)minorChannel Partner/ Reseller/ Distributor · 1 January 2019Kauko is Medixine's partner in Germany, serving the northern market with a telemedicine showroom in Hamburg. Kauko introduced Codeground for industrial customers providing additional training and support resources. Serves the Northern Germany market from Hamburg location.
• EVRY (Sweden)minorChannel Partner/ Reseller/ Distributor · 1 January 2019EVRY presented Medixine Suite at Digitala Vårdmötet in Stockholm, emphasizing connected care, mobile remote monitoring, and patient engagement. The partnership focuses on Swedish healthcare market development.
• GarmincoreTechnology or IntegrationGarmin smartwatches and fitness trackers integrate with Medixine Suite for remote patient monitoring. Garmin devices capture health data including heart rate, activity levels, sleep patterns, and stress metrics, which are seamlessly transmitted to healthcare providers via Medixine Suite. The partnership enables more comprehensive patient monitoring combining consumer wearables with medical-grade monitoring.
• CGIcoreChannel Partner/ Reseller/ DistributorCGI is a strategic partner presenting Medixine Suite at industry events including Vitalis 2022 (stand B07:03). CGI and Medixine collaborate on healthcare digital transformation projects and co-present at trade shows in the Nordic region.
• Surrey Heartlands Health and Care PartnershipminorImplementation/ SI/ Consulting PartnerSurrey Heartlands Health and Care Partnership (Integrated Care System) is part of the TIHM Monitoring Service providing remote monitoring for dementia patients in Surrey, UK, in cooperation with Howz, Medixine Suite, and Surrey and Borders Partnership NHS Foundation Trust.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Luscii: Netherlands-based remote patient monitoring platform offering condition-specific virtual care programs (COPD, heart failure, hypertension) to hospitals and home-care providers. Closely comparable European RPM peer with similar modular platform approach.
• Doccla: UK-based virtual ward and RPM provider delivering condition-specific remote monitoring (respiratory, cardiac, post-surgical) to NHS trusts. Comparable in targeting European public-health systems with hospital-at-home-style offerings.
• Huma: UK-based digital health platform combining RPM, patient-reported outcomes, and AI analytics for hospital systems and pharma. Overlapping target customers (large health systems, biopharma) and platform-based delivery model.
• Biofourmis: US-based RPM platform with strong cardiology and post-acute focus, combining connected biosensors with predictive AI. Comparable in device-agnostic RPM architecture and chronic disease (heart failure) emphasis.
• Vivify Health: US-based RPM and virtual care platform (now part of Optum/UnitedHealth Group) used by health systems and payers. Direct competitor in the multi-condition RPM category with similar kit-of-devices and patient engagement focus.
• CareSimple: US-based RPM platform targeting health systems and home health agencies with cellular-connected devices and condition-specific programs. Comparable in targeting chronic disease patients with plug-and-play device kits.
• Visiba Care: Swedish digital care platform offering video consultations, triage, and asynchronous messaging for healthcare providers. Comparable Nordic peer with similar focus on integrated virtual care workflows for public health systems.
• Health Recovery Solutions: US-based RPM and care transitions platform deployed at hospitals and home health agencies. Comparable in offering condition-specific kits (CHF, COPD, etc.) with tablet-based engagement and integration with connected peripherals.
• TytoCare: Israel-based telehealth platform combining AI-powered remote examination device with provider platform for virtual care. Comparable in combining proprietary device with platform-level RPM/telehealth software for enterprise healthcare buyers.

Broad incumbents

• Philips (HealthSuite/Remote Patient Monitoring): Global healthcare technology conglomerate with a broad RPM and population health portfolio (including post-BiTel收购 assets). Competes with Medixine in RPM but as part of a much larger hospital capital equipment, monitoring, and informatics portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubevimeo.com/user141621291
• LinkedInlinkedin.com/company/medixine-oy
• Instagraminstagram.com/medixxineltd
• Xx.com/medixinecom
• Facebookfacebook.com/medixineltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medixine